TAG:
clinical laboratory testing
Our Editor Gets His Vitamin D Test Results From 9 Different Labs
By Robert Michel | From the Volume XVI No. 11 – August 10, 2009 Issue
CEO Summary: Editor-In-Chief Robert L. Michel gave blood for the cause and it’s another laboratory industry first! To understand what doctors and patients see as national labs use different methodologies and reference ranges to report Vitamin 25(OH) D results, his blood was tes…
Healthcare Reform and Threats to Lab Testing
By Robert Michel | From the Volume XVI No. 9 – June 29, 2009 Issue
CEO SUMMARY: Annual healthcare spending now pushes past $2.5 trillion and this summer’s debate about how to best reform healthcare in the United States will be raucous and emotional. For the laboratory testing industry, the stakes are immense. THE DARK REPORT identifies two pri…
Using Cellphones Like Microscopes To Help Lesser-Developed Countries
By Robert Michel | From the Volume XVI No. 7 – May 18, 2009 Issue
LAB PROFESSIONALS WHO HAVE worked in regions like Africa know that the infrastructure in developing countries is limited or nonexistent. This makes it challenging to provide clinical laboratory testing services that are up to the standards common in developed countries. For example, it can be diffic…
Why Wall Street Likes Histology Lab Business
By Robert Michel | From the Volume XVI No. 6 – April 27, 2009 Issue
CEO SUMMARY: Over the past two decades, investor-owned anatomic pathology companies captured significant market share from community hospital-based pathology groups while delivering profits to their owners. Despite the recent downturn in the economy, Wall Street believes histolog…
ISO 15189 Work Advances at Meeting in Vancouver
By Robert Michel | From the Volume XV No. 8 – June 16, 2008 Issue
CEO SUMMARY: Laboring quietly out of the public eye, an international work team of professionals, including representatives from the CDC, the FDA, and global in vitro diagnostics (IVD) manufacturers, has spent the past 14 years developing an important series of quality and safety standard…
Federal Court Rules on Specimen Ownership
By Robert Michel | From the Volume XV No. 7 – May 27, 2008 Issue
CEO SUMMARY: Recently, a federal appeals court affirmed a district court ruling concerning who owns human tissue specimens that are stored for research and other uses. While most clinical laboratories routinely discard many types of human specimens after use, any research facility or IVD …
Battles Continue Over Doctor Mark Up of Lab Tests
By R. Lewis Dark | From the Volume XV No. 6 – May 5, 2008 Issue
FROM THE SHADOWS OF A PARKING GARAGE, Deep Throat suggests to reporter Bob Woodward, “Follow the money.†In this scene from the movie, All the President’s Men, Woodward gets the right advice he needs from an unnamed source to pursue the Watergate case, a huge political scandal of the 1970s.  
Bostwick Labs Prepares For Public Stock Offering
By Robert Michel | From the Volume XV No. 4 – March 24, 2008 Issue
CEO SUMMARY: In recent years, annual revenue at Bostwick Laboratories has skyrocketed, reaching $102.8 mil- lion in 2007. Now the company, known for its national uropathology expertise, has filed documents in preparation for an initial public stock offering (IPO). Bostwick Laboratories is…
March 03, 2008 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XV No. 3 – March 3, 2008 Issue
Another laboratory company is suing the federal government. On January 24, UroPath, LLC and three urology groups filed a lawsuit in the U.S. District Court for the District of Columbia. UroPath, the largest operator of anatomic pathology (AP) condo/pod laboratory complexes, is suing …
Using a 1997 Bid Model In a 2007 Health Market
By Robert Michel | From the Volume XIV No. 18 – December 31, 2007 Issue
CEO SUMMARY: It’s been a long path from concept to implementation for a competitive bidding demonstration involving clinical lab services. It was in the mid-1980s when CMS commenced work on designing such a demonstration. In the 1990s, RTI International continued devel…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized